Study design (if review, criteria of inclusion for studies)
Parallel design over 10 weeks
Participants
Sham: n = 10, mean (SD) age = 9.76(2.57) Exprimental: n = 10, mean (SD) age = 11.46(2.45)
Interventions
Control: IMT at 10% PImax
Outcome measures
FEV1, VC, FRC, IC, RV, TLC, RV/TLC, FEV1/FVC, MVV, Exercise Time.
Main results
Findings indicated that the experimental group showed significant increases in inspiratory muscle strength, vital capacity, total lung capacity, and exercise tolerance in comparison to the control group.